Recently, over-expression of hnRNPs indicates a poor prognosis for patients with various human cancers [13–16], and genetic polymorphisms of TTP gene but not HuR gene polymorphisms were associated with poor prognosis of breast cancer patients [97]. The gene discussed is ELAVL1; the disease is cancer.